These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1959 related articles for article (PubMed ID: 24652827)

  • 1. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.
    Schwenzer NF; Seith F; Gatidis S; Brendle C; Schmidt H; Pfannenberg CA; laFougère C; Nikolaou K; Schraml C
    Korean J Radiol; 2016; 17(5):684-94. PubMed ID: 27587957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.
    Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M
    J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR.
    de Galiza Barbosa F; Geismar JH; Delso G; Messerli M; Huellner M; Stolzmann P; Veit-Haibach P
    Eur J Radiol; 2018 Jan; 98():165-170. PubMed ID: 29279157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging.
    Stolzmann P; Veit-Haibach P; Chuck N; Rossi C; Frauenfelder T; Alkadhi H; von Schulthess G; Boss A
    Invest Radiol; 2013 May; 48(5):241-6. PubMed ID: 23070096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
    Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
    J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging.
    Chandarana H; Heacock L; Rakheja R; DeMello LR; Bonavita J; Block TK; Geppert C; Babb JS; Friedman KP
    Radiology; 2013 Sep; 268(3):874-81. PubMed ID: 23737537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction.
    Torrado-Carvajal A; Vera-Olmos J; Izquierdo-Garcia D; Catalano OA; Morales MA; Margolin J; Soricelli A; Salvatore M; Malpica N; Catana C
    J Nucl Med; 2019 Mar; 60(3):429-435. PubMed ID: 30166357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and size of pulmonary lesions: how accurate is MRI? A prospective comparison of CT and MRI.
    Heye T; Ley S; Heussel CP; Dienemann H; Kauczor HU; Hosch W; Libicher M
    Acta Radiol; 2012 Mar; 53(2):153-60. PubMed ID: 22287146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?
    Lee KH; Park CM; Lee SM; Lee JM; Cho JY; Paeng JC; Ahn SY; Goo JM
    PLoS One; 2015; 10(6):e0129660. PubMed ID: 26065695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
    Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
    Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.
    Eiber M; Martinez-Möller A; Souvatzoglou M; Holzapfel K; Pickhard A; Löffelbein D; Santi I; Rummeny EJ; Ziegler S; Schwaiger M; Nekolla SG; Beer AJ
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1691-701. PubMed ID: 21688050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results.
    Schäfer JF; Gatidis S; Schmidt H; Gückel B; Bezrukov I; Pfannenberg CA; Reimold M; Ebinger M; Fuchs J; Claussen CD; Schwenzer NF
    Radiology; 2014 Oct; 273(1):220-31. PubMed ID: 24877983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies.
    Zeng F; Nogami M; Ueno YR; Kanda T; Sofue K; Kubo K; Kurimoto T; Murakami T
    Eur Radiol; 2020 Sep; 30(9):4995-5003. PubMed ID: 32300969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.
    Schaarschmidt B; Buchbender C; Gomez B; Rubbert C; Hild F; Köhler J; Grueneisen J; Reis H; Ruhlmann V; Wetter A; Quick HH; Antoch G; Heusch P
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1257-67. PubMed ID: 25852011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.